checkAd
    Startseite > Aktien > BioAdaptives > Nachrichten
    BioAdaptives Aktie
    0,0005
     
    USD
    0,00 %
    0,0000 USD
    Letzter Kurs 17:24:31 Nasdaq OTC
    ISIN: US09072U1079 · WKN: A1XCCG · SYM: BDPT · USA

    Neueste Nachrichten

    BioAdaptives, Inc. Announces NaturaComplete, an All-In-One Supplement to Optimize Its AI-Based FYO Obesity Management System
    22.02.24 · globenewswire · BioAdaptives
    BioAdaptives Announces Low-Cost AI FYO Smartphone App Tracking System to Detect Unwanted Muscle Mass Loss Reported With Obesity Management
    01.02.24 · globenewswire · BioAdaptives
    BioAdaptives Announces Signing of a New Distributor’s Agreement for AI Body Composition Measuring App and New Weight Management System
    17.01.24 · globenewswire · BioAdaptives
    Livestock Impact, Inc., Subsidiary of BioAdaptives, Inc., Launches Innovative Food Lab for Development of Treats and Supplement Powder for Human, Equine, and Canine Products
    04.01.24 · globenewswire · BioAdaptives
    BioAdaptives, Inc. to Form New Division, AI BodyShape Lab, to Promote Adult Fitness and Weight Management
    21.12.23 · globenewswire · BioAdaptives
    BioAdaptives Announces the Development of VeganHepPlusTM Liver Supplement Formula
    16.11.23 · globenewswire · BioAdaptives
    BioAdaptives Highlights Continued Success of Popular LUNG ARMOR System as US Enters Flu Season
    09.11.23 · globenewswire · BioAdaptives
    BioAdaptives Takes Aim at Safe Pain Management with All-Natural Supplement
    02.11.23 · globenewswire · BioAdaptives
    BioAdaptives Targets Multi-Billion Dollar Sleep Market with SleepEZ Natural Supplement
    26.10.23 · globenewswire · BioAdaptives
    BioAdaptives, Inc. Celebrates Nine Years of Commercial Success in Equine Nutrition
    12.10.23 · globenewswire · BioAdaptives
    BioAdaptives Announces Nationwide Launch of Lung Fortress(TM) Natural Supplement
    10.10.23 · Accesswire · BioAdaptives
    BioAdaptives, Inc. Commences Development of a New Supplement for Women’s Health
    05.10.23 · globenewswire · BioAdaptives